FDA Clearance Tracker · P010055-S009
PROSTALUND CORETHERM SYSTEM AND PROSTALAND CORETHERM ACCESSORIES
Last checked: Nov 20, 2026Latest source record: Jul 30, 2014 (this decision)Source: openFDAMethods & limitations
Decided
Jul 30, 2014
Approved
Time to decision
159 days
Received Feb 21, 2014. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track No User Fee
Device class
Class III
The decision
- FDA number
- P010055-S009
- Device name
- PROSTALUND CORETHERM SYSTEM AND PROSTALAND CORETHERM ACCESSORIES
- Applicant
- Prostalund AB
- Applicant location
- Se-223 63 Lund
- Received
- Feb 21, 2014
- Decided
- Jul 30, 2014
- Decision
- Approved
- Supplement type
- Normal 180 Day Track No User Fee
- Reason for supplement
- Location Change - Manufacturer/Sterilizer/Packager/Supplier
- Original approval
- P010055
Device type
- Device class
- Class III
- Specialty
- GI, Urology & NephrologyUrology
FDA's approval statement
As written in FDA's record.
APPROVAL FOR A MANUFACTURING SITE LOCATED AT ORIFICE MEDICAL AB IN YSTAD, SWEDEN.
Source documents
Other decisions for Prostalund AB
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
No other decisions since 2015 under this exact applicant name.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.